Back to Search
Start Over
Consequences of low estimated glomerular filtration rate either before or early after kidney donation.
- Source :
-
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2024 Oct; Vol. 24 (10), pp. 1816-1827. Date of Electronic Publication: 2024 Jun 14. - Publication Year :
- 2024
-
Abstract
- In the general population, decreases in glomerular filtration rate (GFR) are associated with subsequent development of chronic kidney disease (CKD), cardiovascular disease (CVD), and death. It is unknown if low estimated GFR (eGFR) before or early after kidney donation was also associated with these risks. One thousand six hundred ninety-nine living donors who had both predonation and early (4-10 weeks) postdonation eGFR were included. We studied the relationships between eGFR, age at donation, and the time to sustained eGFR<45 (CKD stage 3b) and <30 mL/min/1.73m <superscript>2</superscript> (CKD stage 4), hypertension, diabetes mellitus (DM), CVD, and death. Median follow-up was 12 (interquartile range, 6-21) years. Twenty-year event rates were 5.8% eGFR<45 mL/min/1.73m <superscript>2</superscript> ; 1.2% eGFR<30 mL/min/1.73m <superscript>2</superscript> ; 29.0% hypertension; 7.8% DM; 8.0% CVD; and 5.2% death. The median time to eGFR<45 mL/min/1.73m <superscript>2</superscript> (N = 79) was 17 years, and eGFR<30 mL/min/1.73m <superscript>2</superscript> (N = 22) was 25 years. Both low predonation and early postdonation eGFR were associated with eGFR<45 mL/min/1.73m <superscript>2</superscript> (P < .0001) and eGFR<30 mL/min/1.73m <superscript>2</superscript> (P < .006); however, the primary driver of risk for all ages was low postdonation (rather than predonation) eGFR. Predonation and postdonation eGFR were not associated with hypertension, DM, CVD, or death. Low predonation and early postdonation eGFR are risk factors for developing eGFR<45 mL/min/1.73m <superscript>2</superscript> (CKD stage 3b) and <30 mL/min/1.73m <superscript>2</superscript> (CKD stage 4), but not CVD, hypertension, DM, or death.<br />Competing Interests: Declaration of competing interest The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.<br /> (Copyright © 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Male
Female
Middle Aged
Adult
Follow-Up Studies
Risk Factors
Prognosis
Nephrectomy adverse effects
Kidney Function Tests
Renal Insufficiency, Chronic physiopathology
Renal Insufficiency, Chronic etiology
Tissue and Organ Harvesting adverse effects
Cardiovascular Diseases etiology
Glomerular Filtration Rate
Kidney Transplantation adverse effects
Living Donors
Subjects
Details
- Language :
- English
- ISSN :
- 1600-6143
- Volume :
- 24
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
- Publication Type :
- Academic Journal
- Accession number :
- 38878866
- Full Text :
- https://doi.org/10.1016/j.ajt.2024.04.023